Latest Coronary stent Stories
-- Sustained Safety Profile -- DURHAM, N.C., May 23, 2014 /PRNewswire/ -- Micell Technologies, Inc.
LONDON, May 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile NATICK, Mass., May 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reported
-- Oral Presentations to Include New Long-Term Results from First-in-Human Study -- DURHAM, N.C., May 15, 2014 /PRNewswire/ -- Micell Technologies, Inc.
NATICK, Mass., May 1, 2014 /PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIER(TM) Everolimus-Eluting
- First-of-its-Kind Dissolving Medical Device Being Evaluated in People with Blocked Heart Vessels ABBOTT PARK, Ill., April 10, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced
DALLAS, April 8, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Market Research Report on Global and China Coronary Stent Industry" and "2014 Deep Research Report on Global
DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/znsx2b/global_and ) has announced the addition of the "Global and
These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease NATICK, Mass., April 1, 2014 /PRNewswire/
Allows quick and easy assessment of FFR values with Ultra-Thin Navvus(TM) MicroCatheter that can be used over standard 0.014 inch guidewires EDEN PRAIRIE, Minn., March 29, 2014 /PRNewswire/
- In medieval musical notation, a sign or neume denoting a shake or trill.
More Images (1 images) »